[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-06", "acceptance_datetime": "2025-11-06T12:05:06Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-268045", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-268045/files/glue-20250930_htm.xml", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": -26955000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -26955000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -26955000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -27081000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 36678000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "costs_and_expenses": {"value": 43026000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 45743000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 2717000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 12768000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 82397753.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "diluted_average_shares": {"value": 82397753.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss": {"value": -27081000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -27081000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_income_loss": {"value": -32975000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 9065000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_tax_expense_benefit": {"value": -3177000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -27081000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -30258000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "benefits_costs_expenses": {"value": 43026000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "balance_sheet": {"noncurrent_assets": {"value": 58024000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 14509000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_assets": {"value": 10517000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_current_liabilities": {"value": 39674000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_parent": {"value": 245837000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 7260000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_noncurrent_assets": {"value": 30426000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "cash": {"value": 391300000.0, "unit": "USD", "label": "Cash", "order": 210}, "current_assets": {"value": 401817000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 27598000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 152561000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 459841000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 214004000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 245837000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 61443000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 459841000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": 100428000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 138914000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 138914000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 38138000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 38138000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 348000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 348000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": 100428000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-07", "acceptance_datetime": "2025-08-07T11:06:08Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-104550", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-104550/files/glue-20250630_htm.xml", "financials": {"income_statement": {"operating_expenses": {"value": 38748000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 4458000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 30653000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -12295000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -15554000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -12295000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 82186768.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_tax_expense_benefit": {"value": 1199000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_loss_from_continuing_operations_after_tax": {"value": -12295000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 34290000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 34290000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "other_operating_expenses": {"value": 8095000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -11096000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "basic_average_shares": {"value": 82186768.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "revenues": {"value": 23194000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -12295000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "balance_sheet": {"wages": {"value": 5130000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 5581000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 60121000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 29052000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_assets": {"value": 8865000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "other_noncurrent_assets": {"value": 31069000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 299465000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 359586000.0, "unit": "USD", "label": "Assets", "order": 100}, "cash": {"value": 290600000.0, "unit": "USD", "label": "Cash", "order": 210}, "equity": {"value": 268080000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 359586000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 91506000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 268080000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 41852000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_current_liabilities": {"value": 31141000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -34720000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 25324000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -9031000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 365000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 365000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -9031000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 25324000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -34720000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -12295000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -12339000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-08", "acceptance_datetime": "2025-05-08T11:14:15Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-066372", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-066372/files/glue-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 14000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -145707000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 14000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -145707000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -45492000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -100229000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -45492000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -100229000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "income_statement": {"diluted_average_shares": {"value": 82956423.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": 3671000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": 46885000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 822000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "research_and_development": {"value": 32190000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": 46885000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 8703000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": 44036000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 37222000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss": {"value": 46885000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 40893000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": 47707000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 84929000.0, "unit": "USD", "label": "Revenues", "order": 100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 37222000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": 46885000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 82148719.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": 46912000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": 46885000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"liabilities": {"value": 118039000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_noncurrent_assets": {"value": 31583000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_assets": {"value": 332280000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "wages": {"value": 3841000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 29336000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 393199000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 48886000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 60919000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 393199000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 59216000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 275160000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 275160000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 6489000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "financials": {"comprehensive_income": {"other_comprehensive_income_loss": {"value": 198000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": 12403000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": 12403000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"current_assets": {"value": 377440000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 156946000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 222936000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 8220000.0, "unit": "USD", "label": "Wages", "order": 730}, "noncurrent_assets": {"value": 61292000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "fixed_assets": {"value": 29483000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "accounts_payable": {"value": 17215000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 58850000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_noncurrent_assets": {"value": 31809000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 215796000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 222936000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 438732000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 438732000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_current_liabilities": {"value": 131511000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}}, "income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": 13437000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": 13437000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 47643000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 8777000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 38866000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 2597000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_average_shares": {"value": 2736379.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": 13437000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": 13437000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_average_shares": {"value": 2736379.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_tax_expense_benefit": {"value": 2164000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": 13004000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 45046000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 45046000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": 15601000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 60647000.0, "unit": "USD", "label": "Revenues", "order": 100}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 98634000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": 128922000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -30896000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 98634000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 608000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -30896000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 608000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": 128922000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-07", "acceptance_datetime": "2024-11-07T12:07:48Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-122780", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-122780/files/glue-20240930_htm.xml", "financials": {"income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 27616000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -23859000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -23859000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 71000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_income_loss": {"value": -26527000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "basic_average_shares": {"value": 82011670.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "revenues": {"value": 9216000.0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 2739000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 35743000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -23788000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "diluted_average_shares": {"value": 82011670.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23859000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 8127000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 33004000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_parent": {"value": -23859000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 33004000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "balance_sheet": {"accounts_payable": {"value": 3978000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 63873000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 315080000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 31442000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 205457000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 6703000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 41641000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 315080000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 32431000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "noncurrent_liabilities": {"value": 67982000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 205457000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 30960000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 109623000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 251207000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -23511000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -23511000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -23511000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 37749000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 15000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 16770000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 37749000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 16770000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -20994000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -20994000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 15000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-08", "acceptance_datetime": "2024-08-08T11:04:23Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-093296", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-093296/files/glue-20240630_htm.xml", "financials": {"income_statement": {"revenues": {"value": 4695000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -30310000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": 71233992.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_after_tax": {"value": -30310000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 28055000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -32642000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -30058000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -30310000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30310000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 37337000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "nonoperating_income_loss": {"value": 2584000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_tax_expense_benefit": {"value": 252000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 34753000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 34753000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 9282000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 71233992.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "balance_sheet": {"other_noncurrent_assets": {"value": 32968000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 224671000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 344114000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 42348000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 224671000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 33250000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "wages": {"value": 5143000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 277896000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 30732000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 344114000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 119443000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 66218000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 6473000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 98023000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 98023000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -61158000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 9098000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 9098000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -27767000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -61158000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -27767000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -30287000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -30310000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-09", "acceptance_datetime": "2024-05-09T11:45:32Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-24-056288", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-24-056288/files/glue-20240331_htm.xml", "financials": {"income_statement": {"revenues": {"value": 1064000.0, "unit": "USD", "label": "Revenues", "order": 100}, "research_and_development": {"value": 27026000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -31968000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_before_tax": {"value": -31885000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 36011000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_average_shares": {"value": 60156187.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": 3062000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -31968000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -31968000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": 83000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 8985000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "benefits_costs_expenses": {"value": 32949000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 60156187.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -34947000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 32949000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -31968000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 9853000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 246000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -38165000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -28066000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": 9853000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 246000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -28066000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -38165000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -31968000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -31937000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "accounts_payable": {"value": 6828000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "wages": {"value": 3539000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 199036000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 266746000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 33674000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 114227000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 67710000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 152519000.0, "unit": "USD", "label": "Equity", "order": 1400}, "other_current_liabilities": {"value": 30926000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities_and_equity": {"value": 266746000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 34036000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity_attributable_to_parent": {"value": 152519000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 41293000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": 29634000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 25173000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 25173000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": 14297000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": 29634000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 69104000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 69104000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": 14297000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"noncurrent_liabilities": {"value": 77913000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 46592000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 303755000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 33740000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "accounts_payable": {"value": 11152000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 179250000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 7593000.0, "unit": "USD", "label": "Wages", "order": 730}, "other_current_liabilities": {"value": 27847000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "liabilities": {"value": 124505000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 67543000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 303755000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 33803000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_assets": {"value": 236212000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 179250000.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"income_tax_expense_benefit": {"value": -22000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_after_tax": {"value": -33252000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -33252000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 7728000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -33252000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 1863818.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "operating_income_loss": {"value": -34863000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -33274000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 34863000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 27135000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 1589000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "diluted_average_shares": {"value": 1863818.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_parent": {"value": -33252000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 703000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -34521000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -34521000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-09", "acceptance_datetime": "2023-11-09T21:04:51Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-061995", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-061995/files/glue-20230930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -34699000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -34699000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -34699000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"noncurrent_assets": {"value": 69192000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 184524000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 6145000.0, "unit": "USD", "label": "Wages", "order": 730}, "accounts_payable": {"value": 5500000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities": {"value": 67579000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 10964000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_assets": {"value": 182911000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 184524000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "other_noncurrent_assets": {"value": 34200000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 22609000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 252103000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 34992000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 44970000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 252103000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 28306000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 8662000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 2254000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss": {"value": -34884000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 36968000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -34714000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 49814903.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_income_loss": {"value": -36968000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": 170000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -34884000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_average_shares": {"value": 49814903.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -34884000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -34884000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 35628000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 1101000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -24706000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 35628000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 1101000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -24706000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 12023000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 12023000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-10", "acceptance_datetime": "2023-08-10T11:30:16Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-040959", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-040959/files/glue-20230630_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow": {"value": -5574000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -25324000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 18550000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -25324000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -5574000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 1200000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 1200000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 18550000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -35178000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -35425000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"wages": {"value": 4462000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_liabilities": {"value": 19089000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 213654000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_assets": {"value": 208104000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "fixed_assets": {"value": 35335000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "equity": {"value": 213654000.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 278616000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_current_liabilities": {"value": 9319000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_noncurrent_assets": {"value": 35177000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities_and_equity": {"value": 278616000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 64962000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "accounts_payable": {"value": 5308000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_assets": {"value": 70512000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -35178000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": 2233000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 37221000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -35178000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 8145000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 29076000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "diluted_average_shares": {"value": 49431922.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_tax_expense_benefit": {"value": 190000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -35178000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 49431922.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -37221000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -34988000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -35178000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-11", "acceptance_datetime": "2023-05-11T20:04:43Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-23-021201", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-23-021201/files/glue-20230331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 18000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -3062000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -3062000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -23406000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 18000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -23406000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 20326000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 20326000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"diluted_average_shares": {"value": 49347473.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -32038000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -32038000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -32038000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 26755000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 7504000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -32038000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 34259000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "basic_average_shares": {"value": 49347473.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_after_tax": {"value": -32038000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "nonoperating_income_loss": {"value": 2221000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -34259000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "balance_sheet": {"liabilities": {"value": 65302000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 243726000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 68472000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 309028000.0, "unit": "USD", "label": "Assets", "order": 100}, "accounts_payable": {"value": 7382000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 35206000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "fixed_assets": {"value": 33266000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "other_current_liabilities": {"value": 9960000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "wages": {"value": 3173000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 240556000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 243726000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 309028000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 20515000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -31679000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -32038000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "financials": {"income_statement": {"operating_income_loss": {"value": -32489000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 32489000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 24868000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 1707000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "diluted_average_shares": {"value": 561370, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -30782000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -30782000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -30782000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -30782000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "basic_average_shares": {"value": 561370, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -30782000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "other_operating_expenses": {"value": 7621000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -53939000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -23961000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -57466000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -53939000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 20434000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -23961000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": -57466000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 20434000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 881000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -29932000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -29932000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 12083000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "assets": {"value": 342389000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 25569000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 45407000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 271413000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 275886000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 342389000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 271413000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 66503000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "accounts_payable": {"value": 7862000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_noncurrent_assets": {"value": 39428000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "liabilities": {"value": 70976000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "wages": {"value": 5624000.0, "unit": "USD", "label": "Wages", "order": 730}, "fixed_assets": {"value": 27075000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-10", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-024447", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-024447/files/glue-20220930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -27462000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -27462000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -27462000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 29489000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -217000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 29489000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -20600000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 8672000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 8672000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -20600000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -217000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"fixed_assets": {"value": 19384000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 357603000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 357603000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_noncurrent_assets": {"value": 42984000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity_attributable_to_parent": {"value": 291092000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 66511000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 291092000.0, "unit": "USD", "label": "Equity", "order": 1400}, "accounts_payable": {"value": 9753000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "current_assets": {"value": 295235000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_current_liabilities": {"value": 12037000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 21790000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 62368000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 44721000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "income_statement": {"net_income_loss_attributable_to_parent": {"value": -27318000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_average_shares": {"value": 46732353.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -27318000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": 1044000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 28362000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -27318000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -27318000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_income_loss": {"value": -28362000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 7020000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -27318000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 46732353.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 21342000.0, "unit": "USD", "label": "Research and Development", "order": 1030}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-11", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-016844", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-016844/files/glue-20220630_htm.xml", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_current_liabilities": {"value": 10479000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "current_liabilities": {"value": 14773000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_noncurrent_assets": {"value": 52806000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "equity": {"value": 302050000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 68011000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 302050000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 297045000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 365056000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 63006000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 15205000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 4294000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "liabilities_and_equity": {"value": 365056000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "income_statement": {"research_and_development": {"value": 20936000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "nonoperating_income_loss": {"value": 762000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_expenses": {"value": 27231000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 6295000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -26469000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "diluted_average_shares": {"value": 46668369.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -26469000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_average_shares": {"value": 46668369.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -26469000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -27231000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -26469000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -26469000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 96000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -34654000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -20501000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -20501000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 96000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -14249000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -34654000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": -14249000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -26469000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -26794000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-11", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-22-009324", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-22-009324/files/glue-20220331_htm.xml", "financials": {"income_statement": {"net_income_loss": {"value": -23932000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_average_shares": {"value": -36090, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "income_loss_from_continuing_operations_before_tax": {"value": -23932000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": -36090, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 17915000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "nonoperating_income_loss": {"value": 370000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "income_loss_from_continuing_operations_after_tax": {"value": -23932000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "other_operating_expenses": {"value": 6387000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -23932000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23932000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 24302000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -24302000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -207771000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -27404000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -180520000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -27404000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 153000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -180520000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": 153000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -207771000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -24044000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -23932000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity_attributable_to_parent": {"value": 325875000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 25639000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_noncurrent_assets": {"value": 12243000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "temporary_equity": {"value": 325875000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "fixed_assets": {"value": 13396000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "liabilities_and_equity": {"value": 346005000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 346005000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 12490000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 320366000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "accounts_payable": {"value": 4511000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "other_current_liabilities": {"value": 7979000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 325875000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 20130000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "temporary_equity_attributable_to_parent": {"value": 325875000.0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -23511000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -106000, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -23511000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -14172000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -3047000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -135000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -17354000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -14172000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -17354000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -3047000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -135000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"noncurrent_assets": {"value": 17663000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 366329000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 18814000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_current_liabilities": {"value": 5777000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "equity": {"value": 347515000.0, "unit": "USD", "label": "Equity", "order": 1400}, "wages": {"value": 4303000.0, "unit": "USD", "label": "Wages", "order": 730}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 366329000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_noncurrent_assets": {"value": 5338000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "current_liabilities": {"value": 16638000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 12325000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "temporary_equity": {"value": 347515000.0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "current_assets": {"value": 348666000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "temporary_equity_attributable_to_parent": {"value": 347515000.0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "equity_attributable_to_parent": {"value": 347515000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 2176000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "accounts_payable": {"value": 6558000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -23440000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "nonoperating_income_loss": {"value": -53000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -23440000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_expenses": {"value": 23387000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 5257000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -23440000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "research_and_development": {"value": 18130000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -23387000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23440000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss": {"value": -23440000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-10", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-004138", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-004138/files/glue-20210930_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -20372000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -20372000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -20372000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"noncurrent_liabilities": {"value": 2001000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 369305000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 11801000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "assets": {"value": 384049000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 13530000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "other_current_liabilities": {"value": 9213000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_noncurrent_assets": {"value": 1729000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "liabilities_and_equity": {"value": 384049000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 12743000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 3530000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 369305000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 14744000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 370519000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "cash_flow_statement": {"net_cash_flow": {"value": 9974000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 9974000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 29456000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 29456000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -1688000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -17794000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -1688000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -17794000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -19837000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -19837000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -19837000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "nonoperating_income_loss": {"value": 31000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "operating_income_loss": {"value": -19868000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "other_operating_expenses": {"value": 4753000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -19837000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "research_and_development": {"value": 15115000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_tax_expense_benefit": {"value": 0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 19868000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -19837000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-12", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-21-001372", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-21-001372/files/glue-20210630_htm.xml", "financials": {"balance_sheet": {"other_current_liabilities": {"value": 3328000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "accounts_payable": {"value": 7463000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "current_assets": {"value": 358289000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_noncurrent_assets": {"value": 1729000.0, "unit": "USD", "label": "Other Non-current Assets", "order": 350}, "assets": {"value": 368941000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 356678000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 368941000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 356678000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 12263000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "fixed_assets": {"value": 8923000.0, "unit": "USD", "label": "Fixed Assets", "order": 320}, "current_liabilities": {"value": 10791000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 10652000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -18405000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 18123000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -18405000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -18405000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "nonoperating_income_loss": {"value": -282000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "net_income_loss_attributable_to_parent": {"value": -18405000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 3486000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 14637000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_after_tax": {"value": -18405000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -18123000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -18900000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -18405000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-30", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001826457", "sic": "2836", "tickers": ["GLUE"], "company_name": "Monte Rosa Therapeutics, Inc.", "financials": {"income_statement": {"net_income_loss_available_to_common_stockholders_basic": {"value": -12276000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "nonoperating_income_loss": {"value": -772000, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "research_and_development": {"value": 9273000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 2231000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_attributable_to_parent": {"value": -12276000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -11504000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -12276000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -12276000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -12276000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 11504000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -12276000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -12276000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"current_liabilities": {"value": 60616000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": -60616000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 60616000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": -60616000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}]